Medline
Watchlist
Medline
Medline is a key partner for large healthcare providers
Truist sets a new price target of $52 (Buy)
Jefferies sees an addressable market potential of $375 billion
Reading Time: 1 minute
Medline (MDLN) is one of the most exciting IPO stories following its public offering in December 2025, in my opinion. The Med-Surg supply company has consistently increased its revenues for over 50 years with an average annual growth rate of 18%. With more than 335,000 medical products, it is an indispensable partner for hospitals, nursing facilities, and laboratories. Its 2,000 company-owned vehicles can deliver to 95% of U.S. customers within one day. JPMorgan describes it as a "unique company with significant market share." Through the Prime...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
